Dabur Facility Placed Under Import Alert
The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in
Warning letters, 483s, Recalls, Import Alerts, Audit observations
The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in
The USFDA issued a Form 483 to Strides Pharma Sciences Ltd., Bangalore facility (FEI 3004554612)
USFDA Inspection of Pharmathen’s Rodopi facility in Greece (FEI 3009961173) resulted in issuance of Form
Indoco Remedies’ Goa Plant (FEI 3005124189) received a warning letter from the FDA following critical
Potential contamination of drug products with Diethylene Glycol(DEG), Ethylene Glycol(EG) has severe consequences including fatality